Research

Articles

On December 2nd, 2022, President Joe Biden signed the Medical Marijuana and Cannabidiol Research Expansion Act, the first piece of standalone cannabis legislation in US history to become law. It will reportedly streamline a new process for cannabis research applications and for manufacturing products for drug development and allow for a larger amount of legal cannabis for research purposes.

Historic Medical Marijuana and Cannabidiol Research Expansion Act is Signed into Law

Currently in the life cycle of the cannabis industry, it is not obvious where the heavy metal regulatory landscape will end up. Clearly, the big four are not enough, but what is a realistic panel that reflects the real world of cannabinoid production?

Expanding the Panel of Heavy Metal Contaminants in Cannabis and Hemp Beyond the Big Four:  What Is the Regulatory Evidence Telling Us?

This study, which evaluated the potential of a well-designed unidirectional aseptic processing approach to both hydrocarbon and supercritical carbon dioxide extract manufacturing, suggests that the extraction process is capable of deactivating or removing the tested microbial contaminants when highly contaminated Cannabis spp. Inflorescence is used as feed material.

From Contaminated Cannabis Material to Microbe-Free Extracts: A Real-World Test

The Cannabis & Me research study will reportedly study the effects of cannabis on the human brain, particularly in terms of a user’s prior psychological conditions. 

King’s College London Launches Largest-Ever Independent Study on the Impact of Cannabis Use

In this article, Markus Roggen demonstrates a new method for recapturing terpenes lost during the cannabis extraction process.

Keeping it Clean: Recapturing Terpenes for Added Value and Cleaning Wastewater Streams

The 2022 Canna Pharma Conference was held October 12-13 in San Diego, California.

Highlights from Canna Pharma 2022: Driving Cannabis Science and Therapeutics Forward

In the work presented here, the author shares research from collecting reports from the New Jersey State laboratory (the Department of Health’s Environmental and Chemical Laboratory Services), which has conducted testing for the state’s medicinal program. He documented an average variance of 20% in potency levels from different samples of the same test lot.

Degree of Variance in THC Levels in Samples Taken from Single Lots  of Medical Cannabis

is a Senior Scientist at Agilent Technologies and a Visiting Professor at The Johns Hopkins University School of Medicine in Baltimore, Maryland.

Experts within the global cannabis and hemp industries discuss the importance of testing and regulations and sustainable measures that can reduce the sector’s environmental impact.

How Manufacturing, Regulations, and Sustainability Are Affecting the Cannabis and Hemp-Based Products Industry

Kevin McKernan, Chief Scientific Officer and Founder of Medicinal Genomics, shares some insight behind his recently published paper related to cannabis trichomes and positive results on rapid yeast and mold plates.

New Research Shows that Cannabis Trichomes Trigger Positive Results on Rapid Yeast and Mold Plates

In his presentation for the psychedelics track at Cannabis Science Conference East 2022, James Schwartz, BSN, LNC, presented “A New Beginning for an Old Therapy: Case Series Review on the Treatment of PTSD and Other Psychiatric Disorders with Psilocybin and Other Psychedelics.” He reviewed the current research and clinical trials studying the effects of psilocybin, plus side effects, potential uses, latest trends, disorders currently being studied, and potential future applications. Schwartz was a trauma trained nurse who worked in the Trauma/Critical Care ICU at Oregon Health and Science University. He is an experienced medical legal consultant and CEO of Cascade High. Here are some highlights from his session.